Search

everythinglearnresearchcommunity

for

Search:↓

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Most patients improved with oral contraceptives, but some needed additional treatment.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

The testes produce important hormones like testosterone and others that play key roles in male body functions.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

New compounds may soon be tested to treat excessive hair growth in women.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Most women with Polycystic Ovary Syndrome (PCOS) have skin issues like excessive hair, acne, or hair loss. Hormone imbalances are common, and age, certain hormones, and hormone ratios can predict acne. Obesity, infertility, and high cholesterol are also common in these women.

Some skin diseases and their treatments can negatively affect male fertility.

High testosterone increases heart disease risk in women with PCOS.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Pubertal acne is linked to hormonal changes, affects quality of life, and is treated similarly to adult acne.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Agaricus subrufescens improves ovarian function and biochemical health in rats with PCOS.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.